Background:The adoption of a second dose of the measles-mumps-rubella(MMR)vaccine among Taiwan residents school children began in 2001.However,during that time,mumps cases continued to occur.The purpose of the present...Background:The adoption of a second dose of the measles-mumps-rubella(MMR)vaccine among Taiwan residents school children began in 2001.However,during that time,mumps cases continued to occur.The purpose of the present study was to assess the epidemiology and vaccination policy for mumps in Taiwan.Methods:We examined the data on mumps cases collected by the Taiwan Centers for Disease Control(Taiwan CDC)between 2006 and 2011.Results:During the 6-year study period,a total of 6612 cases of mumps were reported to the Taiwan CDC.Of the patients with known vaccination status,62%received one dose of the MMR vaccine or no vaccine.The incidence of mumps ranged from 4.18 to 5.28 per 100000 population and peaked in 2007.Males had a higher incidence of mumps than females(5.9 vs.3.7 per 100000 population;P=0.024).Children between 5 and 6 years of age had the highest incidence of mumps,and those 20 years and older had the lowest incidence.Compared to those who received two doses of the MMR vaccine,patients who were not vaccinated or received a single dose of the vaccine had a higher risk of suffering from complications and/or hospitalization.Conclusions:In Taiwan,more than 60%of mumps cases received either no dose or one dose of the MMR vaccine.Monitoring mumps through biological testing and instituting a second dose of the MMR vaccine for children is needed for the elimination of mumps in Taiwan.展开更多
基金supported by a grant(NSC 101-2314-B-006-055)from the National Science Council,Taiwan of China
文摘Background:The adoption of a second dose of the measles-mumps-rubella(MMR)vaccine among Taiwan residents school children began in 2001.However,during that time,mumps cases continued to occur.The purpose of the present study was to assess the epidemiology and vaccination policy for mumps in Taiwan.Methods:We examined the data on mumps cases collected by the Taiwan Centers for Disease Control(Taiwan CDC)between 2006 and 2011.Results:During the 6-year study period,a total of 6612 cases of mumps were reported to the Taiwan CDC.Of the patients with known vaccination status,62%received one dose of the MMR vaccine or no vaccine.The incidence of mumps ranged from 4.18 to 5.28 per 100000 population and peaked in 2007.Males had a higher incidence of mumps than females(5.9 vs.3.7 per 100000 population;P=0.024).Children between 5 and 6 years of age had the highest incidence of mumps,and those 20 years and older had the lowest incidence.Compared to those who received two doses of the MMR vaccine,patients who were not vaccinated or received a single dose of the vaccine had a higher risk of suffering from complications and/or hospitalization.Conclusions:In Taiwan,more than 60%of mumps cases received either no dose or one dose of the MMR vaccine.Monitoring mumps through biological testing and instituting a second dose of the MMR vaccine for children is needed for the elimination of mumps in Taiwan.
